Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss

Overview of attention for article published in Frontiers in oncology, April 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,812 followers.

Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss https://t.co/iNEs2XHs7Z

15 May 2023

Reply Repost Favourite

Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss https://t.co/PfcGGyRqYG

15 May 2023

Reply Repost Favourite

New research: Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss: Purpose To establish a high-risk prediction model for aromatase inhibitor-associated bone loss (AIBL) in patients with hormone… #oncology ht

07 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.